1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
QUALCOMM filed a prospectus supplement on July 31, 2026, covering the resale by selling stockholders of 17,826,566 common shares. The company issued these shares as consideration for its previously announced acquisition of Modular Inc, agreed on June 21, 2026. The filing shows the shares can now be resold under a registration statement, and it does not disclose any financial results.
Prospectus supplement filed July 31, 2026 covers resale of 17,826,566 shares of common stock.
Shares were issued as consideration for the Modular Inc acquisition, agreed June 21, 2026, in a private placement exempt from registration.
Resale terms are governed by a Registration Rights Agreement dated July 28, 2026 with Shareholder Representative Services LLC.
At its July 30, 2026 annual meeting, Kyndryl stockholders approved an amended and restated 2021 Long-Term Performance Plan that adds 7,600,000 shares issuable under the plan. Stockholders also elected six directors, approved executive compensation on an advisory basis, and ratified PricewaterhouseCoopers LLP as auditor for the fiscal year ending March 31, 2027.
Amended plan increases shares issuable by 7,600,000 shares of common stock
Executive compensation approved on an advisory basis with 75% of votes present in favor
Plan approval received 94% of votes present; 139,325,459 votes for
PricewaterhouseCoopers LLP ratified as auditor with 97% of votes present in favor
At its July 27, 2026 annual meeting, Milestone Scientific stockholders re-elected five directors, approved raising authorized common stock from 125,000,000 to 135,000,000 shares, and approved increasing the share reserve under its 2020 Equity Incentive Plan from 11,500,000 to 28,750,000 shares. A larger pool of authorized and plan shares gives the company room to issue more stock in the future. The board also re-elected Kelly Ulto and Greg Shilling as directors and named them to committee roles.
Stockholders approved the authorized share increase with 22,541,526 shares for and 795,607 against, or 96.59% of votes cast.
Stockholders approved the equity plan increase with 18,716,361 shares for and 4,440,070 against, or 80.82% of votes cast.
Kelly Ulto was named Audit Committee chair and Greg Shilling was named Compensation Committee chair, effective with the July 2026 board action.
Shares voted totaled 44,335,594, representing 50.12% of the 88,449,412 shares outstanding at the record date.
ORIC Pharmaceuticals' board approved an amended and restated 2022 Inducement Equity Incentive Plan effective July 28, 2026, adding 1,100,000 shares for a total of 3,350,000 shares reserved for equity awards. The plan was adopted without stockholder approval under Nasdaq rules and is limited to inducement grants to new hires or acquisition-related awards, so it adds to potential future share issuance.
Board approved an additional 1,100,000 shares, bringing the total reserved under the Inducement Plan to 3,350,000 shares of common stock.
Approved effective July 28, 2026, and adopted without stockholder approval under Nasdaq Listing Rules.
Awards may be granted only to individuals not previously employees or non-employee directors, as an inducement to employment or, where permitted, in connection with a merger or acquisition.
The full plan is filed as Exhibit 10.1 to the 8-K.
Central Plains Bancshares, Inc. said its Board approved on July 28, 2026 a submission to regulators for a new stock repurchase program covering up to 417,481 shares, about 10.0% of current outstanding shares. The program would replace the company's current repurchase program once adopted, and it cannot proceed without regulatory non-objection.
Board approved regulatory submission of new repurchase program on July 28, 2026
Program covers up to 417,481 shares, approximately 10.0% of current outstanding shares
Upon adoption, the new program would replace the current repurchase program
Details were disclosed in a press release dated July 29, 2026 (Exhibit 99.1)
Lite Strategy said it bought back about 4.9 million shares, or 13% of shares outstanding when the program began, from December 2025 through July 17, 2026, at an average price of $1.11 for about $5.4 million. The company said the buybacks were funded from Litecoin sales and covered call premiums, and that its NAV discount narrowed from the low 40% range to below 25%, which raises Litecoin held per remaining share. The company also reported preliminary, unaudited fiscal year-end cash of $5.7 million and total liabilities of $1.1 million.
About 4.9 million shares repurchased through July 17, 2026, at an average price of $1.11, for about $5.4 million.
Company held 819,070 LTC against 31,882,648 shares outstanding as of July 17, 2026.
NAV discount narrowed to below 25% from the low 40% range during the repurchase period.
Preliminary, unaudited cash of $5.7 million and total liabilities of $1.1 million as of June 30, 2026; final results may differ materially.
Southern Cross Acquisition I Corp., a blank check company, said holders of 11,500,000 units may separately trade the ordinary shares, warrants and rights included in the units starting July 31, 2026. The shares, warrants and rights will trade on Nasdaq under the symbols NCO, NCOOW and NCOOR, while unseparated units continue under NCOOU. The move is administrative and does not change the company's business or target search.
Separate trading of ordinary shares, warrants and rights begins on or about July 31, 2026.
Ordinary shares, warrants and rights trade as NCO, NCOOW and NCOOR; units remain NCOOU.
Holders must have brokers contact transfer agent Continental Stock Transfer & Trust Company to separate units.
Futurewave Acquisition Corporation, a blank check company, said holders of its units may separately trade the ordinary shares, rights and warrants included in the units starting on or about July 31, 2026. Units not separated will keep trading under FWACU, and the separated securities are expected to trade under FWAC, FWACR and FWACW. The change is administrative and does not alter the securities' terms or the company's business.
Separate trading of ordinary shares, rights and warrants expected to begin on or about July 31, 2026
Separated securities expected to trade as FWAC (shares), FWACR (rights) and FWACW (warrants) on Nasdaq Capital Market
Each whole warrant entitles the holder to buy one ordinary share at $11.50; holders must work through their brokers with Continental Stock Transfer & Trust Company to separate units
At its July 28, 2026 annual meeting, FuboTV stockholders approved a restated 2020 Equity Incentive Plan that adds 7,000,000 shares and removes the plan's fixed term, and approved a charter amendment that removes extra voting requirements for removing Hulu-designated directors. The Board also appointed CEO Alisa Bowen as a director on July 29, 2026, and all eight director nominees were elected.
Restated 2020 plan adds 7,000,000 shares and caps incentive stock options at 14,593,054 shares.
Certificate of Amendment removing extra voting requirements for Hulu designee removal was filed July 28, 2026.
Alisa Bowen, Chief Executive Officer, was appointed to the Board on July 29, 2026.
Holders of about 88.61% of outstanding common stock (96,086,692 shares) were represented at the meeting, based on the June 2, 2026 record date.
On July 23, 2026, Deep Fission's Board amended its Non-Employee Director Compensation Policy to better align pay with market practice. The annual equity award rises to $175,000 and the initial award for new directors to $350,000, with higher committee chair and new member retainers.
Annual equity award increased to $175,000; initial award for newly appointed directors increased to $350,000
Committee chair retainers: Audit $25,000; Compensation and NomGov $15,000 each
New committee member retainers: Audit $10,000; Compensation $7,500; NomGov $5,000
All incremental amounts paid through restricted stock units with a one-year vesting condition
On July 27, 2026, KIDZ AI's board raised the company's share repurchase program by 50%, from $2.0 million to up to $3.0 million of Class B common stock. The filing says repurchases may be made in open market, block or privately negotiated transactions, are not obligatory, and may be suspended or discontinued at any time. The press release says the increase follows an open letter to shareholders from the CEO and the market's response to it, but the filing gives no revenue, earnings or guidance figures.
Board authorized the increase on July 27, 2026, from $2.0 million to up to $3.0 million.
Repurchases may be made under Rule 10b-18, in open market, block or privately negotiated transactions, at the company's discretion.
The press release says the increase follows an open letter to shareholders from the CEO, but the 8-K is signed by CEO Hui Luo, while the press release names CEO Stephanie Luo.
Fundrise Innovation Fund (VCX) said it is moving the expiration of the post-listing lockup on shares acquired before February 20, 2026 up by one month, from September 14, 2026 to August 13, 2026. Locked-up shares would become eligible to trade on August 14, 2026. The filing says the fund's investment strategy, portfolio and operations are unaffected.
Lockup expiration moves from September 14, 2026 to August 13, 2026, one month earlier.
Shares acquired before February 20, 2026 that remain locked up can begin trading on August 14, 2026.
Management says the lockup has served its primary purpose of supporting orderly price discovery.
The fund states its investment strategy, portfolio and ongoing operations are unaffected.
Snow Rothschild Acquisition Corp. announced that holders of its IPO units may separately trade the Class A ordinary shares and warrants starting July 30, 2026. Units not separated will keep trading under ISNRU, and the separation does not change the terms of the shares or warrants.
Separate trading of Class A ordinary shares (ISNR) and warrants (ISNRW) starts July 30, 2026 on the Nasdaq Global Market.
Each unit consists of one Class A ordinary share and one-half of one redeemable warrant; each whole warrant entitles the holder to buy one share for $11.50.
Only whole warrants will trade; no fractional warrants will be issued on separation.
Unit holders must have their brokers contact Continental Stock Transfer & Trust Company, the transfer agent, to separate units.
On July 23, 2026, Concentrix's Board adopted an Amended and Restated Executive Severance Plan that replaces its Change of Control Severance Plan, following an annual compensation review. The amended plan raises severance for executives terminated without cause within two months before or 12 months after a change of control, and adds severance for such terminations outside that window.
Plan adopted July 23, 2026, replacing the Change of Control Severance Plan.
Change-of-control severance changes from salary continuation of 18 to 24 months to two times base salary plus target bonus, less withholding.
New severance of base salary plus target bonus, less withholding, applies to terminations outside the change-of-control window.
Plan adds a 'best-net' Section 280G cut-back provision; full plan filed as Exhibit 10.1.
OneMedNet's board set September 18, 2026 as the date for its 2026 Annual Meeting of Stockholders, with a record date of August 11, 2026. Because the meeting date moved more than 30 days from the anniversary of the December 17, 2025 meeting, the company updated its deadlines for stockholder proposals and director nominations to August 5, 2026. The filing is administrative and does not report financial results.
2026 Annual Meeting set for September 18, 2026; record date August 11, 2026
Stockholder proposals and director nominations must be received by August 5, 2026
Proposals must be sent to the Secretary at 6385 Old Shady Oak Road, Eden Prairie, Minnesota
Matters to be voted on will be detailed in a future definitive proxy statement
Corpay's Compensation Committee approved special performance-based restricted stock unit grants to Ronald F. Clarke and Armando L. Netto on July 22, 2026. The awards vest only if Corpay's stock closes at or above $425.00, $450.00 or $475.00 on five separate trading days before August 31, 2028, and are meant to align their pay with shareholder stock price gains and aid retention.
Grant date July 22, 2026; performance period runs through August 31, 2028
Clarke received 300,000 PSUs; Netto received 28,213 PSUs
Vesting tiers tied to stock price hurdles of $425.00, $450.00 and $475.00 on five separate trading days
At its July 22, 2026 annual meeting, Constellation Brands stockholders approved an amended and restated Long-Term Stock Incentive Plan, extending it to July 22, 2036 and reserving 6,000,000 additional Class A shares for future grants. All 12 director nominees were elected, and the company also ratified KPMG LLP as its auditor and approved the executive compensation advisory vote.
Plan term extended through July 22, 2036, with a reserve of 6,000,000 Class A shares for future grants.
Plan amendment approved with 141,885,558 votes for and 2,943,598 against.
All 12 director nominees elected to serve until the 2027 annual meeting; E. Morgan Flatley appointed to the Human Resources Committee.
KPMG LLP ratified as independent auditor for the fiscal year ending February 28, 2027, with 149,792,033 votes for.
Natural Gas Services Group, Inc. completed the move of its legal domicile from Colorado to Texas on July 20, 2026, after shareholder approval at its June 10, 2026 annual meeting. The company states that its headquarters, business, management, assets, liabilities and listing on the New York Stock Exchange under the symbol NGS did not change, but shareholder rights are now governed by Texas law. The filing also reports new indemnification agreements with directors and executive officers effective July 20, 2026.
Redomestication to Texas effective July 20, 2026; shareholders approved it at the June 10, 2026 annual meeting.
Each outstanding share converted into one share of the Texas corporation; stock certificates do not need to be exchanged.
Company states no change to headquarters, management, employees, assets, liabilities or net worth, other than transaction costs.
Indemnification agreements with directors and executive officers replaced prior agreements, effective July 20, 2026.
Lake Shore Bancorp's Board declared a cash dividend of $0.09 per share on July 22, 2026, payable August 12, 2026 to shareholders of record as of August 3, 2026. The filing describes a routine quarterly-style dividend declaration and does not report financial results, guidance, or other changes to the company.
Dividend amount: $0.09 per share on outstanding common stock
Declared by the Board of Directors on July 22, 2026
Payment date: August 12, 2026; record date: August 3, 2026
Announced in press release Exhibit 99.1 dated July 24, 2026
Kontoor Brands declared a regular quarterly cash dividend of $0.53 per share, payable September 18, 2026, to shareholders of record on September 8, 2026. On July 22, 2026, the board also increased its size from six to seven directors and appointed Thomas E. Waldron, a former Kontoor executive, as a director.
Quarterly cash dividend of $0.53 per share, announced July 24, 2026
Dividend payable September 18, 2026; record date September 8, 2026
Thomas E. Waldron appointed director effective July 22, 2026, with a term expiring at the 2027 annual meeting
Waldron previously served as Executive Vice President and Chief Operating Officer of Kontoor
QXO filed a prospectus supplement covering resale by certain selling stockholders of 41,405,099 common shares issuable on conversion of Series C preferred stock, plus 96,267 shares of that preferred stock. The filing satisfies QXO's registration obligations under a January 5, 2026 Investment Agreement, and it does not state any proceeds to the company.
Resale covers 41,405,099 common shares issuable on conversion of Series C Convertible Perpetual Preferred Stock
Also covers 96,267 shares of Series C preferred stock
Filed July 23, 2026 under Form S-3ASR registration statement first filed July 29, 2024
Filed to meet obligations under the Investment Agreement dated January 5, 2026
At its annual meeting on July 23, 2026, Uranium Energy Corp. stockholders elected all six director nominees, ratified PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending July 31, 2026, and approved the non-binding advisory vote on executive compensation. The company also reported that its board re-appointed Amir Adnani as President and CEO and Josephine Man as CFO, Treasurer and Secretary, which is routine for shareholders as the votes confirm the current board and management structure.
Quorum: 360,697,854 shares, about 72.9% of the 494,872,366 shares outstanding as of the May 29, 2026 record date, were present in person or by proxy.
Directors: all six nominees were elected, including Amir Adnani with 284,913,462 votes for and 21,324,498 withheld.
Auditor: PricewaterhouseCoopers LLP was ratified with 357,342,477 votes for and 2,895,792 against.
Say-on-pay: executive compensation was approved with 299,936,455 votes for, 5,059,182 against and 1,242,323 abstentions.
Delek US Holdings, Inc. said its Board of Directors approved a quarterly dividend of $0.255 per share. The dividend is payable August 10, 2026, to shareholders of record on August 3, 2026, so holders on that record date will receive the payment.
Quarterly dividend of $0.255 per share approved by the Board
InterPrivate Investment Partners V, Inc., a blank check company, announced that holders of its IPO units may elect to separately trade Class A ordinary shares and warrants starting on or about July 27, 2026. The change affects how existing unit holders can trade their securities and does not alter the terms of the warrants, which carry an $11.50 exercise price per share.
Separate trading of Class A ordinary shares and warrants begins on or about Monday, July 27, 2026.
Separated shares and warrants will trade on Nasdaq under IPVV and IPVVW; unseparated units continue under IPVVU.
Each unit holds one Class A ordinary share and one-third of one warrant; each whole warrant exercises at $11.50 per share.
Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate units.
On July 22, 2026, Domo's board adopted a tax benefits preservation plan and declared a dividend of one preferred stock purchase right per Class A and Class B common share, held by holders of record on August 4, 2026. The plan aims to deter any person or group from acquiring 4.9% or more of the company's securities, which could trigger an ownership change that limits use of net operating losses. The filing header names Huckleberry.ai, Inc. (HUCK), but the body refers only to Domo, Inc., so the registrant identity should be confirmed.
Board adopted the plan and declared the rights dividend on July 22, 2026; record date is August 4, 2026.
Each right's exercise price is $17.50, subject to adjustment, and the rights expire at the close of business on July 20, 2029, subject to earlier events.
Acquiring Person threshold is 4.9% of outstanding common stock; the plan is not expected to interfere with Board-approved mergers.
Equiniti Trust Company, LLC is named as rights agent.
Fossil Group's board set October 2, 2026 as the date for its 2026 Annual Meeting of Stockholders, with August 3, 2026 as the record date for determining who may vote. The filing also sets July 30, 2026 as the deadline for stockholder proposals and director nominations under the company's bylaws, a routine procedural step with no financial results disclosed.
2026 Annual Meeting set for October 2, 2026 at 9:00 a.m. Central Time; location to be specified in the proxy statement
Record date for voting is August 3, 2026
Stockholder proposal and director nomination notices due by close of business July 30, 2026, at the Richardson, Texas headquarters
Damora Therapeutics completed its redomestication from Delaware to the Cayman Islands, effective July 16, 2026, after stockholders approved it at a February 9, 2026 special meeting. The company says the move does not change its business, management, obligations, assets or liabilities, and its shares continue to trade on Nasdaq under the symbol DMRA, now under a new CUSIP. The filing states that certain shareholder rights changed as a result, so holders should review the Cayman articles.
Redomestication effective July 16, 2026; stockholders approved it at a February 9, 2026 special meeting.
Ordinary shares began trading under new CUSIP G2646Y104 at the open on July 20, 2026; Nasdaq symbol remains DMRA.
Cayman memorandum and articles of association now govern the company in place of its Delaware charter and bylaws; certain shareholder rights changed.
Directors and executive officers entered into new indemnification agreements on July 16, 2026.
Grayscale Investments Sponsors, LLC, sponsor of the Grayscale Sui Staking ETF, intends to sign Amendment No. 2 to the trust agreement on or around August 7, 2026. The amendment would require the trust to convert staking consideration to cash at least quarterly and distribute the net proceeds to shareholders, so shareholders could receive regular cash distributions for the first time under this framework. The filing says distribution amounts will depend on staking consideration actually received and cannot be predicted with certainty.
Proposed Amendment No. 2 to the trust agreement is expected on or around August 7, 2026, with trustee CSC Delaware Trust Company.
Trust would sell staking consideration to cash no less often than quarterly and distribute net proceeds, after trust expenses not assumed by the sponsor.
The sponsor gave shareholders 20 days' prior notice and states the amendment is not materially adverse to shareholders.
The sponsor, Grayscale Investments Sponsors, LLC, intends to enter a Third Amended and Restated Declaration of Trust and Trust Agreement on or around August 7, 2026. The amendment would require the trust to convert staking consideration to cash at least quarterly and distribute the net proceeds to shareholders, though the amount of each distribution depends on staking rewards actually received and cannot be predicted with certainty. The sponsor says the change is intended to conform to IRS Revenue Procedure 2025-31, and it is giving shareholders 20 days' prior notice.
Proposed amendment is expected to take effect on or around August 7, 2026.
Trust would convert staking consideration to cash no less often than quarterly and distribute net cash proceeds to shareholders.
Sponsor gave 20 days' prior notice to shareholders; the filing says distribution amounts cannot be predicted with certainty.
Trust intends to file a Rule 424(b)(3) prospectus supplement upon execution, and filed tax and risk factor supplements as Exhibits 99.1 and 99.2.
The Sponsor, Grayscale Investments Sponsors, LLC, intends to sign Amendment No. 2 to the Trust Agreement with trustee CSC Delaware Trust Company on or around August 7, 2026. The amendment would require the Trust to convert staking consideration to cash at least quarterly and distribute the net cash proceeds to Shareholders, and the amount of each distribution will depend on the staking consideration actually received and cannot be predicted with certainty.
The Sponsor intends to enter into Amendment No. 2 on or around August 7, 2026, with CSC Delaware Trust Company as trustee.
The amendment would require the Trust to reduce staking consideration to cash no less often than quarterly and distribute net proceeds to Shareholders.
Net proceeds are after Trust expenses not assumed by the Sponsor, which may include a portion of staking consideration paid to the Sponsor for facilitating staking.
The Sponsor gave Shareholders 20 days' prior notice, and the filing is dated July 17, 2026.
Bassett Furniture Industries announced on July 16, 2026 that its Board declared a regular quarterly dividend of $0.20 per share. Shareholders of record at the close of business on August 14, 2026 will receive the payment on August 28, 2026. The filing covers only the dividend declaration and does not include financial results.
Regular quarterly dividend of $0.20 per share of common stock declared
Record date is the close of business on August 14, 2026
Polaryx Therapeutics' board set its 2026 Annual Meeting of Stockholders to be held virtually on September 10, 2026, with a July 27, 2026 record date. The filing also sets a July 27, 2026 deadline for stockholder proposals and director nominations to be considered for the proxy materials, because the company held no annual meeting in 2025.
Annual Meeting to be held virtually on September 10, 2026
Stockholders of record at close of business on July 27, 2026 may vote
Deadline for stockholder proposals and director nominations for proxy inclusion is close of business on July 27, 2026
Company may change the record date, meeting date and location before the meeting
Tribeca Strategic Acquisition Corp. said that starting July 20, 2026, holders of its IPO units may separate the units into Class A ordinary shares and share rights for separate trading on Nasdaq. Units not separated will keep trading as BIDWU, and the company's filing does not describe any change to its business or financial results.
Separate trading of Class A ordinary shares (BID) and share rights (BIDWR) begins July 20, 2026
Unseparated units continue to trade on Nasdaq under BIDWU
Each right entitles the holder to one-tenth of one Class A ordinary share upon completion of an initial business combination
Unit holders must have their brokers contact transfer agent Efficiency, INC. to separate units
Bone Biologics' board voted on July 15, 2026 to postpone the annual stockholder meeting from August 11 to September 28, 2026, so an additional proposal can be included in the proxy statement and stockholders have more time to review it. The company also moved the record date to August 6, 2026 and the deadline for director nominations and other proposals to July 26, 2026. The change is administrative and does not state any financial results.
Annual meeting moved from August 11, 2026 to September 28, 2026, at 11:30 a.m. Eastern Time in Burlington, Massachusetts
New record date set for August 6, 2026
Stockholder deadline for director nominees or proposals is now July 26, 2026
Company plans to file a Definitive Proxy Statement on Schedule 14A with an additional stockholder proposal
On July 15, 2026, Cannae Holdings closed the sale of its interest in Brasada Ranch to a company owned by director William P. Foley, II. In the same transaction, the company and Mr. Foley signed a letter agreement that deletes a provision of his Director Services Agreement allowing him to sell 50% of his Cannae common stock back to the company at defined prices.
Sale of Cannae's Brasada Ranch interest to a Foley-owned company closed on July 15, 2026.
Letter Agreement dated July 15, 2026 deletes Section 11(a) of the Director Services Agreement dated May 12, 2025.
Deleted Section 11(a) had allowed Mr. Foley to sell 50% of his Cannae shares back to the company at defined prices.
The full Letter Agreement is filed as Exhibit 10.1.
Lamb Weston amended its 2026 Inducement Stock Plan on July 13, 2026, reducing the number of common shares authorized for issuance under the plan from 2,000,000 to 1,538,000. The plan is used to grant equity to new hires and returning employees, so the change limits the shares available for those grants.
Amendment adopted July 13, 2026 by the Compensation and Human Capital Committee
Authorized shares reduced from 2,000,000 to 1,538,000
Plan covers individuals not previously employed by the company or returning after a bona fide period of non-employment
Gladstone Land's board authorized repurchases of up to $20 million of its 6.00% Series B preferred stock and up to $35 million of its 6.00% Series C preferred stock, running through July 14, 2027. The company is not obligated to buy any particular amount, and the program can be suspended or discontinued at any time, so the effect on preferred holders and common shareholders will depend on how much is actually bought.
Series B authorization: up to $20,000,000 (Nasdaq: LANDO)
Series C authorization: up to $35,000,000 (Nasdaq: LANDP)
Program expires July 14, 2027; repurchases may be made through open market or privately negotiated transactions
The Procter & Gamble Company declared a quarterly dividend of $1.0885 per share on its common stock and its Series A and Series B ESOP Convertible Class A Preferred Stock. Common shareowners of record at the close of business on July 24, 2026 will receive the payment, which is due on or after August 17, 2026. The release states P&G has paid a dividend for 136 consecutive years and has increased it for 70 consecutive years.
Quarterly dividend of $1.0885 per share on common and ESOP preferred stock
Common stock record date is July 24, 2026; payment on or after August 17, 2026
Company states it has increased its dividend for 70 consecutive years and paid one for 136 consecutive years
A Delaware Court of Chancery approved on June 30, 2026 a settlement of the Dollens shareholder lawsuit, and on July 8, 2026 Goosehead and its pre-IPO stockholders signed an Amended and Restated Stockholders Agreement. While those holders own at least 10% of common shares, they must approve certain major corporate actions and may nominate a majority of the board, including the Chairman, which gives them more influence over governance than other common stockholders have.
On June 30, 2026, the Court of Chancery of the State of Delaware approved the settlement of the Dollens Action (C.A. No. 2022-1018-JTL).
The A&R Stockholders Agreement, dated July 8, 2026, applies while pre-IPO holders beneficially own at least 10% of outstanding common stock.
Pre-IPO holders must approve mergers or sales of substantially all assets, asset deals above 15% of total assets, equity issuances above $50 million, charter amendments, and changes to board size.
Pre-IPO holders may nominate a majority of the board, including the Chairman, but the board need not endorse those nominees if its fiduciary duties require otherwise.
RMG ML Sports Holdings, a special purpose acquisition company, said holders of units from its June 11, 2026 IPO may separately trade ordinary shares and rights starting on or about July 17, 2026. The filing is administrative: it changes how the securities trade, but it reports no financial results, deal terms, or change in the company's business.
Separate trading of ordinary shares (SHOT) and rights (SHOTR) starts on or about July 17, 2026.
Units not separated continue to trade under SHOTU on The Nasdaq Global Market.
Each unit holds one ordinary share and one right to receive one-eighth of an ordinary share upon an initial business combination.
Holders must have brokers contact transfer agent Continental Stock Transfer & Trust Company to separate units.
At its July 7, 2026 annual meeting, Cellectar Biosciences stockholders approved adding 2,000,000 shares to the 2021 Stock Incentive Plan and approved exercising warrants for up to 39,618,078 shares of common stock under Nasdaq rules. Stockholders also elected Andrew Gu and Douglas J. Swirsky to three-year terms and ratified Deloitte & Touche LLP as auditor for fiscal 2026, so the vote could increase the share count available to shareholders.
Plan amendment approved: 1,706,640 for, 439,422 against, 13,825 abstain
Warrant exercise for up to 39,618,078 shares approved: 1,881,936 for, 55,004 against, 222,946 abstain
Andrew Gu and Douglas J. Swirsky elected as Class III directors for three-year terms
Non-binding say-on-pay vote approved: 1,438,422 for, 712,362 against
Shareholders of the NXG Cushing Midstream Energy Fund approved a new investment advisory agreement with Cushing Asset Management, LP, after NXG Cushing, LLC acquired a 62% interest in the Adviser from its founder on July 10, 2026. The filing states the new agreement has no material differences from the prior one and does not change the advisory fee rate, so the change mainly affects who controls the Adviser rather than the Fund's terms.
Shareholders elected Brian R. Bruce and John H. Alban as Class I Trustees, each to serve until the 2029 annual meeting.
Annual meeting was held June 18, 2026 and adjourned to July 10, 2026.
Advisory fee remains 1.25% of Average Weekly Managed Assets; Adviser waives 0.25% of Managed Assets through February 1, 2027.
NXG Cushing, LLC now owns 62% of the Adviser and replaced Swank Capital, LLC as general partner.
Neuraxis declared a second quarter 2026 dividend on its Series B Preferred Stock, to be paid in common stock rather than cash. The filing says about 80,463 common shares are expected to be issued, based on accrued dividends from April 1, 2026 divided by $2.38 per share.
About 80,463 shares of common stock are expected to be issued for the dividend.
Shares are calculated from accrued, unpaid dividends from April 1, 2026 through the record date, divided by $2.38.
Holders of record as of July 21, 2026 will receive the dividend on July 29, 2026.
Fractional shares will be paid in cash at $2.38 per share of Series B Preferred Stock.
Yorkville International Capital Corp., a blank check company, said holders of its IPO units may separately trade Class A ordinary shares and warrants starting July 13, 2026. The change affects how the units can be traded and does not involve a business combination, financial results or a change to the warrant terms.
Separate trading of Class A ordinary shares (YICC) and warrants (YICCW) begins July 13, 2026
Each unit consists of one Class A ordinary share and one-third of one warrant, exercisable at $11.50 per share
Units not separated continue to trade under the symbol YICCU on the Nasdaq Global Market
Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate units
NioCorp's board ratified a Company-wide annual cash incentive program (AIP) and approved fiscal 2026 AIP payouts for employees, including named executive officers. Payouts to the CEO, CFO and COO total $1.33 million, paid or expected in cash on or about July 15, 2026, and the filing says the company will provide more detail in a later SEC filing.
Board ratified the AIP and fiscal 2026 award payouts on July 2, 2026, on the recommendation of the Compensation Committee.
Fiscal 2026 payouts: Mark A. Smith (CEO) $602,784, paid to 76 Resources, LLC; Neal S. Shah (CFO) $345,621; Scott Honan (COO) $378,197.
Fiscal 2026 awards weighted 45% on Board-approved corporate milestones, 10% on safety and 45% on individual objectives.
No cash bonuses were approved for named executive officers for fiscal 2025.
GSR V Acquisition Corp., a blank check company, said holders of its Public Units can separately trade Class A ordinary shares and rights starting July 2, 2026, under the tickers GSRV and GSRVR. Units not separated will keep trading as GSRVU. The change is administrative and does not alter the terms of the shares or rights, which convert into Class A ordinary shares only upon completion of an initial business combination.
Separate trading of Class A ordinary shares and rights begins July 2, 2026.
Each unit consists of one Class A ordinary share and one-seventh of one right; each whole right entitles the holder to one Class A ordinary share upon an initial business combination.
Separated shares and rights trade as GSRV and GSRVR on Nasdaq; unseparated units continue as GSRVU.
Holders must have brokers contact Odyssey Transfer and Trust Company, the transfer agent, to separate units.
Launch One Acquisition Corp. said its sponsor converted 5,749,999 Class B ordinary shares into Class A shares on July 6, 2026, leaving 28,749,999 Class A and 1 Class B ordinary share outstanding. The company is asking shareholders at an extraordinary general meeting to extend its deadline to complete a business combination from July 15, 2026 to January 15, 2027, and it and its sponsor may enter non-redemption agreements that are expected to improve the chances of approval and keep more money in the trust account.
Sponsor converted 5,749,999 Class B ordinary shares into Class A shares on July 6, 2026; 28,749,999 Class A and 1 Class B ordinary share are outstanding afterward.
Extension Amendment Proposal would move the business combination deadline from July 15, 2026 to January 15, 2027.
Non-redemption agreements would have investors agree not to redeem or to rescind redemptions and to vote for the extension; the sponsor expects to transfer Class A shares to those investors after a business combination closes, at a ratio ye
Proxy statement was filed June 10, 2026 and mailed on or about June 12, 2026 to holders of record as of May 15, 2026.
The VanEck Avalanche ETF's sponsor declared the trust's first cash distribution, totaling $140,003, to shareholders of record on July 7, 2026. The payment comes from proceeds of AVAX staking rewards earned from January 8, 2026 through June 30, 2026, after fees, costs, expenses, taxes, liabilities and reserves, so shareholders receive a cash payout tied to the trust's staking activity.
Aggregate distribution of $140,003, the trust's first cash distribution
Record date July 7, 2026; shares expected to trade ex-dividend on July 7, 2026
Payment date July 8, 2026
Covers staking rewards earned January 8, 2026 through June 30, 2026, after fees and reserves
Patriot Acquisition Corp., a blank check company, said holders of its units may separately trade the Class A ordinary shares and warrants starting July 6, 2026. The change is administrative and does not alter the terms of the shares or warrants, which each whole warrant exercisable at $11.50 per share.
Separation of units into Class A ordinary shares and warrants is effective July 6, 2026
Separated shares and warrants trade on Nasdaq as PTAC and PTACW; unseparated units continue as PTACU
Each unit includes one Class A ordinary share and one-half of one redeemable warrant; each whole warrant is exercisable for $11.50 per share
Registration statement relating to the securities was declared effective May 13, 2026
Immersion Corporation set October 7, 2026 as the date of its fiscal 2026 annual stockholder meeting and set July 13, 2026 as the deadline for stockholder proposals and director nominations. The Board also declared a quarterly cash dividend of $0.075 per share, payable July 31, 2026 to holders of record on July 20, 2026, which shareholders receiving dividends will note.
Annual meeting set for Wednesday, October 7, 2026; location to be set in the proxy statement
Deadline for stockholder proposals and director nominations is close of business July 13, 2026
Quarterly cash dividend of $0.075 per share, payable July 31, 2026 to holders of record on July 20, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.